BioCardia Inc (BCDA)
4.62
-0.58
(-11.15%)
USD |
NASDAQ |
May 31, 16:00
4.62
0.00 (0.00%)
After-Hours: 20:00
BioCardia Enterprise Value: 7.461M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 7.461M |
| May 30, 2024 | 8.517M |
| May 29, 2024 | 8.468M |
| May 28, 2024 | 8.608M |
| May 24, 2024 | 8.498M |
| May 23, 2024 | 7.990M |
| May 22, 2024 | 7.496M |
| May 21, 2024 | 10.14M |
| May 20, 2024 | 9.754M |
| May 17, 2024 | 9.754M |
| May 16, 2024 | 9.866M |
| May 15, 2024 | 9.970M |
| May 14, 2024 | 9.864M |
| May 13, 2024 | 9.732M |
| May 10, 2024 | 9.688M |
| May 09, 2024 | 9.798M |
| May 08, 2024 | 9.637M |
| May 07, 2024 | 9.422M |
| May 06, 2024 | 9.436M |
| May 03, 2024 | 9.258M |
| May 02, 2024 | 9.126M |
| May 01, 2024 | 9.159M |
| April 30, 2024 | 9.452M |
| April 29, 2024 | 8.992M |
| April 26, 2024 | 9.170M |
| Date | Value |
|---|---|
| April 25, 2024 | 8.938M |
| April 24, 2024 | 9.247M |
| April 23, 2024 | 9.153M |
| April 22, 2024 | 8.933M |
| April 19, 2024 | 8.724M |
| April 18, 2024 | 9.180M |
| April 17, 2024 | 8.941M |
| April 16, 2024 | 8.836M |
| April 15, 2024 | 9.089M |
| April 12, 2024 | 9.514M |
| April 11, 2024 | 9.335M |
| April 10, 2024 | 9.786M |
| April 09, 2024 | 9.592M |
| April 08, 2024 | 9.458M |
| April 05, 2024 | 9.396M |
| April 04, 2024 | 9.383M |
| April 03, 2024 | 9.598M |
| April 02, 2024 | 9.778M |
| April 01, 2024 | 9.678M |
| March 31, 2024 | 9.974M |
| March 28, 2024 | 9.777M |
| March 27, 2024 | 10.10M |
| March 26, 2024 | 9.781M |
| March 25, 2024 | 9.392M |
| March 22, 2024 | 9.496M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.781M
Minimum
Sep 18 2023
81.90M
Maximum
Jul 31 2019
26.34M
Average
23.99M
Median
Enterprise Value Benchmarks
| Retractable Technologies Inc | -13.51M |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.267M |
| Revenue (Quarterly) | 0.055M |
| Total Expenses (Quarterly) | 2.33M |
| EPS Diluted (Quarterly) | -1.35 |
| Profit Margin (Quarterly) | -4.12K% |
| Earnings Yield | -152.6% |
| Normalized Earnings Yield | -152.60 |